Cargando…
Sphingolipid metabolism and drug resistance in ovarian cancer
Despite progress in understanding molecular aberrations that contribute to the development and progression of ovarian cancer, virtually all patients succumb to drug resistant disease at relapse. Emerging data implicate bioactive sphingolipids and regulation of sphingolipid metabolism as components o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936734/ https://www.ncbi.nlm.nih.gov/pubmed/31891125 http://dx.doi.org/10.20517/cdr.2018.06 |